Baricitinib vs Insulin Glargine
Baricitinib vs Insulin Glargine: Overview
This comparison examines the pharmacological differences between Baricitinib and Insulin Glargine.
Mechanism of Action
Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.
Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.
Pharmacokinetics
Half-life: Baricitinib — 12 hours; Insulin Glargine — 12-24 hours.
Chemical Properties
Molecular Formula: Baricitinib — C16H17N7O2S.
Molecular Weight: Baricitinib — 371.4170 g/mol.
Type: Baricitinib — Small molecule; Insulin Glargine — Protein.